Gatifloxacin Carboxyclic Acidum Ethyl Ester CAS 112811-71-9 Puritas >99.0% (HPLC)
Shanghai Ruifu Chemical Co, Ltd. est primarius fabrica Gatifloxacin Carboxyclic Acidum Ethyl Ester (CAS: 112811-71-9) cum qualitate alta.Ruifu Chemical traditio totius terrarum, quantitatis competitive pretium, optimum servitium, parvas et moles in promptu habere potest.Purchase Gatifloxacin et Moxifloxacinum hydrochloridum intermedia;Please contact: alvin@ruifuchem.com
| Nomen chemicum | Gatifloxacin Carboxyclic Acidum Ethyl Ester |
| Synonyma | Ethyl 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylatum;Ethyl 1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydroquinoline-3-Carboxylatum;1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylic Acidum Ethyl Ester;1-Cyclopropyl-6,7-Difluoro-8-Methoxy-4-Oxo-1,4-Dihydro-Quinoline-3-Carboxylic Acidum Ethyl Ester;Gatifloxacin Carboxyclic Acidum Ethyl Ester;Moxifloxacin Difluoro Methoxy Ethyl Ester |
| Stock Status | In Stock, Commercial Productio |
| CAS Number | 112811-71-9 |
| Formulae hypotheticae | C16H15F2NO4 |
| M. Pondus | 323.30 g/mol |
| Liquescens punctum | 182.0 ad 186.0℃ |
| Density | 1.414±0.06 g/cm3 |
| Sensitiva | Calor Sensitiva |
| COA & MSDS | Praesto |
| Origin | Shanghai, China |
| Brand | Ruifu Chemical |
| Items | Specifications | Proventus | Test Methodi |
| Aspectus | Off-White Crystalline pulveris | Obsequitur | By Physical Observationem |
| Puritas / Analysis Methodus | >99.0% (HPLC) | 99.80% | HPLC |
| Liquescens punctum | 182.0~18.0℃ | 182.5~ 185.5℃ | CP2005 Version Second Part Addendum VI C |
| Damnum in Siccatio | <0.50% | 0.08% | CP2005 Version Second Part Addendum VIII L |
| Residere in Ignition | <0.20% | 0.08% | CP2005 Version Second Part Addendum VIII N |
| una immunditia | <0.50% | 0.06% | HPLC |
| Totalis immunditias | <1.00% | 0.20% | HPLC |
| 1H NMR Imaginum | Congruunt Structure | Obsequitur | |
| conclusio | Productum probatum est et cum datis specificationibus obsequitur | ||
| Applicationem | Medium Gatifloxacin / Moxifloxacinum Hydrochloridum | ||
Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Continentem arcte clausam et in loco frigido, sicco (2~8℃) reponunt et a cellis bene ventilatis ab substantiis incompossibilibus.A lumine et humore protege, ignem et calorem vitare.
Naviportans:Libera ad mundum ab aere, per FedEx / DHL Express.Ieiunium et certas traditiones provide.
Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com
15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.
Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.
Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.
Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.
Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.
Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.
MOQ?Nec MOQ.Parvus ordo placet.
Tempus adferendi? Si intus prosapia, tres dies partus praestatur.
Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.
Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.
Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.
Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.
Ethyl 1-Cyclopropyl-6,7-Difluoro-1,4-Dihydro-8-Methoxy-4-Oxo-3-Quinolinecarboxylatum (Gatifloxacin Carboxyclic Acidum Ethyl Ester) (CAS: 112811-71-9) est medium Gatifloxacin (. CAS: 112811-59-3) / Moxifloxicum hydrochloridum (CAS: 186826-86-8).
Gatifloxacin est generatio quarta-fluoroquinolonorum pertinens ad catervam racemicam 8-methofluoroquinolonorum, cum lato spectro microorganismi et activitatis anti-gram-negativae et positivi, a Iaponico Xinglin pharmaceutico Co., Ltd. R-et S-enantiomers eiusdem activitatis antibacterial, inhibito bacterial DNA gyrasi et topoisomerasi IV, quae replicationem, transcriptionem et processum ad operandum bacterial DNA inhibet, validum effectum antibacterial in variis bacteria habet, habet. effectus bonus in infectio systematis respiratorii et infectio systematis generationis, et est una ex repraesentativis "fluoroquinolonum respiratorii", quae his annis celeriter creverunt.Fuscus maxime in curatione variarum lenium ad moderandas morbos infectiosos per pathogens sensitivos causatos, incluso: exacerbationem acutam bronchitis chronici, sinusitici acuti, Pneumonia sacra quaesita, infectio tractus urinarii simplex (cystitis) et infectio tractus urinarii multiplex, cystitis, acuta. Pyelonephritis et infectiones urethrae, cervicis, rectum, ex Neisseria gonorrhoeae causatur.
Moxifloxacin hydrochloridum est fluoroquinolonum antibioticum a Bayer Pharmaceuticis in Germania elaboratum.Eius mechanismus actionis et in vitro spectro antibacteriali similes sunt aliis medicamentis fluoroquinolonis, sed eius actio antibacterial contra bacterium gram-positivum et bacteria anaerobica simile cum travaxacin (trovafloxacin), quod melius est quam nonnullas veteres varietates.Comparati cum aliis fluoroquinolonibus, bacteria gra-positiva huic producto repugnant, paucae vel tardissimae sunt.Crux bacteria repugnans cum aliis fluoroquinolonibus inventae sunt in Bacteria Gram-negativa et Enterococcus.Productum autem hoc saltem efficax est ad staphylococcus aureus isolatus grlA,grlB, gyrA seu gyrB.Productum hoc ciprofloxacin-repugnans staphylococcus aureus inhibere potest 0.5~2 mg/L, et est ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin et moxifloxacin descendendo secundum mic.
